CSS LLC’s Trillium Therapeutics Inc. TRIL Stock Holding History

CSS LLC’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-219,400	Closed	-$3.85M	–	1535
2021 Q3	$3.85M	Buy	219,400 +105,500	+93%	+$1.23M	0.16%	116
2021 Q2	$1.1M	Buy	113,900 +46,100	+68%	+$434K	0.05%	385
2021 Q1	$729K	Sell	67,800 -14,600	-18%	-$181K	0.03%	473
2020 Q4	$1.21M	Buy	82,400 +41,200	+100%	+$594K	0.05%	282
2020 Q3	$585K	Sell	41,200 -157,400	-79%	-$1.57M	0.03%	394
2020 Q2	$1.61M	Buy	198,600 +11,000	+6%	+$68K	0.09%	203
2020 Q1	$758K	Buy	+187,600	New	+$709K	0.06%	245

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

CSS LLC's TRIL Position: Q4 2021 in Review

CSS LLC sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 116,154 shares — an estimated $2.04M sold.

CSS LLC first reported a position in TRIL in Q1 2020 and held it in 6 quarters. The position peaked at $2.04M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

CSS LLC reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
CSS LLC sold 116,154 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $2.04M.
CSS LLC first reported a position in Trillium Therapeutics Inc. in Q1 2020 and held it in 6 quarters.
CSS LLC's Trillium Therapeutics Inc. position peaked at $2.04M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on CSS LLC's 13F filing for Q4 2021, filed 14 Feb 2022.